Bevacizumab and recurrent malignant gliomas: A European perspective - Reply Journal Article


Authors: Friedman, H. S.; Prados, M. D.; Wen, P. Y.; Mikkelsen, T.; Schiff, D.; Abrey, L. E.; Yung, W. K. A.; Paleologos, N.; Nicholas, M. K.; Jensen, R.; Vredenburgh, J.; Huang, J.; Zheng, M.; Cloughesy, T.
Article Title: Bevacizumab and recurrent malignant gliomas: A European perspective - Reply
Keywords: vasculotropin; overall survival; bevacizumab; drug approval; temozolomide; letter; progression free survival; drug screening; procarbazine; glioblastoma; nitrosourea; corticosteroid; astrocytoma; phase 2 clinical trial (topic); phase 3 clinical trial (topic)
Journal Title: Journal of Clinical Oncology
Volume: 28
Issue: 12
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2010-04-20
Start Page: e190
End Page: e192
Language: English
DOI: 10.1200/jco.2009.26.9472
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 1" - "Export Date: 20 April 2011" - "CODEN: JCOND" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lauren E Abrey
    278 Abrey